Matt Spraker (@sprakermdphd) 's Twitter Profile
Matt Spraker

@sprakermdphd

Oncologist and Talking Head | ❤️ @mellysprakes, Aayla, Brooklyn the Dog, and the mountains

ID: 18726720

linkhttp://www.sprakermd.com calendar_today07-01-2009 16:20:55

18,18K Tweet

4,4K Takipçi

803 Takip Edilen

Mark Cuban (@mcuban) 's Twitter Profile Photo

"Here’s a wild-but-true factoid: 10 of the 20 largest companies on the new Fortune 500 list derive profit from the 340B program. I guess you can’t throw off tens of billions of profits without titans of industry figuring out how to get their hands on it" (Brian Reid) 🧵

NIH (@nih) 's Twitter Profile Photo

“It is absolutely vital that NIH investments are geographically dispersed. The way we combat scientific groupthink is by empowering researchers across the country, no matter where they are, to have a great opportunity if they have great ideas for NIH funding.” - Jay Bhattacharya, MD, PhD

Matt Spraker (@sprakermdphd) 's Twitter Profile Photo

New song, new art, we're back for Season 4! S4E1 is the sequel to our prior episode on the Advanced Practice Radiation Therapist! Is scope creep coming for Rad Onc now too? We host Join Y. Luh, MD (he/him/dude/他) and RadLady1987 for the physician perspective on this vital conversation 😍

New song, new art, we're back for Season 4!

S4E1 is the sequel to our prior episode on the Advanced Practice Radiation Therapist! 

Is scope creep coming for Rad Onc now too? 

We host <a href="/j_luh/">Join Y. Luh, MD (he/him/dude/他)</a> and <a href="/Haleyml1987/">RadLady1987</a> for the physician perspective on this vital conversation 😍
Matt Spraker (@sprakermdphd) 's Twitter Profile Photo

Fun fact: the S4 art was hidden in the first TAP travel award hardware from the ACRO - American College of Radiation Oncology meeting. It's like an easter egg. For myself. Because Im a huge nerd and making TAP is really fun.

David Sher (@davidshermd) 's Twitter Profile Photo

Lymphopenia and ENI It has been long established that H&N radiation leads to lymphopenia, which can last several months. The adverse prognostic impact of lymphopenia has also been shown. However, specific predictors of lymphopenia are poorly understood. Our experience of

Percy Lee MD (@percyleemd) 's Twitter Profile Photo

Shankar Siva Biniam Kidane I read this thread with interest, a mindset to understand. The premise is simply illogical. Patients on this study had SABR followed by surgery, non standard double local therapy. To then use this and point to these patients’ reduced QOL and attributed to SABR alone is wrong.

Matt Spraker (@sprakermdphd) 's Twitter Profile Photo

Immunotherapy has been a boon for our patients with gynecologic cancers. But so has radiotherapy. For >100 years. Come on Merck 😭

Immunotherapy has been a boon for our patients with gynecologic cancers. 

But so has radiotherapy. 

For &gt;100 years. 

Come on <a href="/Merck/">Merck</a> 😭
Parisa Shams (@p_shams_) 's Twitter Profile Photo

“Can I lift weights after #breast #cancer?” A question filled with fear and uncertainty. Our new study in JAMA Network Open brings good news! Let’s rewrite the narrative of #survivorship together ASTRO #exercise #oncology

Abdulaziz AlGhamdi (@azphotons) 's Twitter Profile Photo

On that note, I wonder if radiation oncology will ever have a community like Radiopaedia one where we can share full stacks of images, volumes, DVHs, and meaningful discussions, all driven by the same communal spirit. It can feel quite lonely in radiation oncology at times.

Daniel E Spratt (@drspratticus) 's Twitter Profile Photo

Exciting to bring the tech to USA. I hope the lessons on proton are not repeated. Over 40,000 patients have been treated with carbon ion worldwide. Unclear what cancers this enhances your ability to treat. It is ok to bring new tech and do research with it and not claim it is

Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

4/ Locoregional therapy (LRT) = core pillar 🔸TACE: modest LC, but still widely used 🔸Ablation: great for small tumors 🔸SBRT: 80–90% LC, non-invasive, helpful for portal vein involvement, 1L option even for TACE eligible 🔸Y90: Personalized dosimetry is changing the game

Laura E Flores, MD, PhD (@lauraflowerse) 's Twitter Profile Photo

Running an exercise trial is hard (see our Heartland Osteoporosis Prevention supervised exercise trial) - this is a nice breakdown of the pros/cons of the recent NEJM trial For clinicians advising patients, @YMCA offers a FREE survivorship program with an included membership 💪